On March 7, 2024, the board of directors of IIOT-OXYS, Inc., a Nevada corporation (the "Company"), approved and ratified the Company entering into the Debt Exchange Agreement (the "Agreement") dated February 5, 2024 with Cambridge MedSpace LLC, an entity of which the Company's CEO, Clifford L. Emmons shares ownership (the "Lender"). Under the Agreement, the Company agreed to issue to the Lender 57 shares of Series C Preferred Stock in exchange for the forgiveness of $68,825 of principal ($55,000) and accrued and unpaid interest.
Attachments
Original Link
Permalink
Disclaimer
IIOT-OXYS Inc. published this content on
13 March 2024 and is solely responsible for the information contained therein. Distributed by
Public, unedited and unaltered, on
13 March 2024 17:51:07 UTC.
IIOT-OXYS, Inc. develops hardware, software and algorithms that monitor, measure and predict conditions for energy, structural, agricultural and medical applications. It uses domain-specific artificial intelligence to solve industrial and environmental challenges. Its engineered solutions are focused on common sense approaches to machine learning, algorithm development and hardware and software products. It uses off-the-shelf components, with reconfigurable hardware architecture that adapts to a range of customer needs and applications. It uses open-source software tools, while still creating proprietary content for customers. The software works with the hardware to collect data from the equipment or structure that is being monitored. It develops algorithms that help its customers create insights from vast data streams. The data collected is analyzed and reports are created for the customer. From these insights, the customer can act to improve their process, product or structure.
IIOT-OXYS, INC. 
